Analyst consensus rating
NewGenIvf Group Analyst Rating: none
NIVF is rated none by 1 analysts with a $42.36 target. As of 2026-09-02.
Direct answer
NewGenIvf Group's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $42.36.
Forecast evidence checked September 2, 2026.
Get free NewGenIvf Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.33
- Average price target
- $42.36
- High price target
- $42.36
- Low price target
- $42.36
- Low target gap
- +3,085%
- Target upside
- +3,085%
- High target gap
- +3,085%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for NewGenIvf Group?
NewGenIvf Group has a verified none consensus. The same dataset has an average price target of $42.36.
How far are NewGenIvf Group's low and high targets from the recorded price?
The low target implies +3,085%, while the high target implies +3,085%.
How many analysts are included in NewGenIvf Group's consensus?
The verified consensus includes 1 analysts.
How is NewGenIvf Group's target upside or downside calculated?
The average target of $42.36 is divided by the recorded price of $1.33, then one is subtracted to produce +3,085%. This does not guarantee a future return.
When was NewGenIvf Group's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.